Tienan Yi

569 total citations
15 papers, 79 citations indexed

About

Tienan Yi is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, Tienan Yi has authored 15 papers receiving a total of 79 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Oncology, 5 papers in Pulmonary and Respiratory Medicine and 3 papers in Surgery. Recurrent topics in Tienan Yi's work include Lung Cancer Treatments and Mutations (4 papers), Plasma Diagnostics and Applications (3 papers) and Gastric Cancer Management and Outcomes (3 papers). Tienan Yi is often cited by papers focused on Lung Cancer Treatments and Mutations (4 papers), Plasma Diagnostics and Applications (3 papers) and Gastric Cancer Management and Outcomes (3 papers). Tienan Yi collaborates with scholars based in China, Australia and Canada. Tienan Yi's co-authors include Xing Huang, Xiong Jin, Y. Chen, Zhen Zhang, Jia Tang, Dan Liu, Yue Lu, Zhen Wang, Xiaoren Zhang and Zhiming Hu and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Annals of Oncology.

In The Last Decade

Tienan Yi

9 papers receiving 77 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Tienan Yi China	3	46	37	24	15	10	15	79
Adrien Procureur France	4	44 1.0×	21 0.6×	17 0.7×	16 1.1×	4 0.4×	6	68
Larissa Klaase Netherlands	5	35 0.8×	32 0.9×	22 0.9×	20 1.3×	4 0.4×	7	71
Alexei Hernandez United States	5	40 0.9×	25 0.7×	30 1.3×	12 0.8×	18 1.8×	12	78
Leena Tiainen Finland	6	63 1.4×	31 0.8×	68 2.8×	11 0.7×	26 2.6×	12	125
Kaitlin Wyllie Australia	4	28 0.6×	13 0.4×	37 1.5×	12 0.8×	16 1.6×	5	84
Consuelo Martinez China	3	60 1.3×	46 1.2×	44 1.8×	8 0.5×	26 2.6×	3	118
Mila Volchek Australia	3	47 1.0×	24 0.6×	27 1.1×	15 1.0×	14 1.4×	5	81
Andrea García-Garijo Spain	2	46 1.0×	13 0.4×	29 1.2×	7 0.5×	20 2.0×	3	73
Shusuke Kawashima Japan	4	32 0.7×	28 0.8×	22 0.9×	8 0.5×	8 0.8×	6	61
Kenneth Grossman United States	5	46 1.0×	26 0.7×	30 1.3×	18 1.2×	7 0.7×	8	108

Countries citing papers authored by Tienan Yi

Since Specialization

Citations

This map shows the geographic impact of Tienan Yi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tienan Yi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tienan Yi more than expected).

Fields of papers citing papers by Tienan Yi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tienan Yi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tienan Yi. The network helps show where Tienan Yi may publish in the future.

Co-authorship network of co-authors of Tienan Yi

This figure shows the co-authorship network connecting the top 25 collaborators of Tienan Yi. A scholar is included among the top collaborators of Tienan Yi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tienan Yi. Tienan Yi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

Zhang, Zhongkai, Tienan Yi, Zun Zhang, et al.. (2025). Collisional radiative model based investigation on the color appearance of xenon plasma in Hall thruster plumes. Plasma Sources Science and Technology. 34(1). 15015–15015.

Huang, Ge, Jing Zhang, Tienan Yi, et al.. (2025). The Application of the Posterior Atlanto-Occipital Membrane Tension Release Technique for Surgical Exposure of the Horizontal Part of the Vertebral Artery's Third Segment: An Anatomical and Clinical Investigation. World Neurosurgery. 194. 123597–123597. 1 indexed citations

Wang, Jie, Nong Yang, Dongqing Lv, et al.. (2025). Savolitinib (Savo) combined with osimertinib (osi) versus chemotherapy (chemo) in EGFR-mutant (EGFRm) and MET -amplification ( MET amp) advanced NSCLC after disease progression (PD) on EGFR tyrosine kinase inhibitor (TKI): Results from a randomized phase 3 SACHI study.. Journal of Clinical Oncology. 43(17_suppl). 3 indexed citations

Yi, Tienan, et al.. (2025). The sputtering-deposition balance in the beam and backflow regions of electric propulsion plume. Acta Astronautica. 235. 512–524.

Liu, Zhong, et al.. (2025). The Application of the Prevertebral Fascia in the Surgical Approach to the Craniocervical Junction: Cadaveric Dissection Studies and Clinical Case Demonstrations. World Neurosurgery. 202. 124376–124376.

Dinglin, Xiao-Xiao, Yongsheng Li, Qing Wen, et al.. (2025). BAT8008, a TROP-2 antibody-drug conjugate (ADC), in patients with advanced solid tumor: Results from a phase 1 study.. Journal of Clinical Oncology. 43(16_suppl). 3024–3024.

Hao, Guanghui, Zhongkai Zhang, Tienan Yi, et al.. (2024). Ignition mechanism of a dual trigger electrode hollow cathode. Plasma Sources Science and Technology. 33(11). 115022–115022.

Yu, Yang, Adam Cooper, Jermaine Coward, et al.. (2024). 478O Updated results of oral PD-L1 inhibitor ABSK043 in advanced solid tumor patients (pts) from a phase I study. Annals of Oncology. 35. S1580–S1580.

Wu, Xiaohua, Jing Wang, Danbo Wang, et al.. (2024). Fruquintinib plus sintilimab in treated advanced endometrial cancer (EMC) patients (pts) with PMMR status: Results from a multicenter, single-arm phase 2 study.. Journal of Clinical Oncology. 42(16_suppl). 5619–5619. 2 indexed citations

10.

Wu, Xian, Dong Wang, Jing Wang, et al.. (2023). 289MO Fruquintinib plus sintilimab in advanced cervical cancer (CC) patients (pts): Results from a multicenter, single-arm phase II study. Annals of Oncology. 34. S1587–S1587. 1 indexed citations

11.

Zhou, Keshu, Yuqin Song, Tienan Yi, et al.. (2023). IMM01 Plus Tislelizumab in Prior Anti-PD-1 Failed Classic Hodgkin Lymphoma: An Open Label, Multicenter, Phase 2 Study (IMM01-04) Evaluating Safety As Well As Preliminary Anti-Tumor Activity. Blood. 142(Supplement 1). 609–609. 2 indexed citations

12.

Ba, Yi, Shukui Qin, Lu Wen, et al.. (2018). Development of non-hematological adverse events in apatinib-treated gastric cancer and their association with clinical outcome: Results from a phase IV study.. Journal of Clinical Oncology. 36(15_suppl). 4039–4039. 1 indexed citations

13.

Li, Jin, Lu Wen, Junsheng Wang, et al.. (2018). Safety of apatinib as third-line or beyond treatment in advanced or metastatic gastric cancer: Results from a multicenter phase IV study (Ahead-G201).. Journal of Clinical Oncology. 36(15_suppl). e16019–e16019. 1 indexed citations

14.

Huang, Xing, et al.. (2012). Prognostic value of TP/PD-ECGF and thrombocytosis in gastric carcinoma. European Journal of Surgical Oncology. 38(7). 568–573. 22 indexed citations

15.

Li, Jin‐Long, Zhen Zhang, Tienan Yi, et al.. (2011). Low-dose paclitaxel enhances the anti-tumor efficacy of GM-CSF surface-modified whole-tumor-cell vaccine in mouse model of prostate cancer. Cancer Immunology Immunotherapy. 60(5). 715–730. 46 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact